When knowledge of a heritable gene mutation comes out of the blue: Treatment-focused genetic testing in women newly diagnosed with breast cancer

B. Meiser, V.F. Quinn, M. Gleeson, J. Kirk, K.M. Tucker, B. Rahman, Christobel Saunders, K.J. Watts, M. Peate, Elizabeth Geelhoed, K. Barlow-Stewart, M. Field, M. Harris, Y.C. Antill, G. Mitchell

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

© 2016 Macmillan Publishers Limited, part of Springer Nature.Selection of women for treatment-focused genetic testing (TFGT) following a new diagnosis of breast cancer is changing. Increasingly a patient's age and tumour characteristics rather than only their family history are driving access to TFGT, but little is known about the impact of receiving carrier-positive results in individuals with no family history of cancer. This study assesses the role of knowledge of a family history of cancer on psychosocial adjustment to TFGT in both women with and without mutation carrier-positive results. In-depth semistructured interviews were conducted with 20 women who had undergone TFGT, and who had been purposively sampled to represent women both family history and carrier status, and subjected to a rigorous qualitative analysis. It was found that mutation carriers without a family history reported difficulties in making surgical decisions quickly, while in carriers with a family history, a decision regarding surgery, electing for bilateral mastectomy (BM), had often already been made before receipt of their result. Long-term adjustment to a mutation-positive result was hindered by a sense of isolation not only by those without a family history but also those with a family history who lacked an affected relative with whom they could identify. Women with a family history who had no mutation identified and who had not elected BM reported a lack of closure following TFGT. These findings indicate support deficits hindering adjustment to positive TFGT results for women with and without a family history, particularly in regard to immediate decision-making about risk-reducing surgery.
Original languageEnglish
Pages (from-to)1517-1523
JournalEuropean Journal of Human Genetics
Volume24
Issue number11
DOIs
Publication statusPublished - 2016

Fingerprint

Genetic Testing
Breast Neoplasms
Mutation
Genes
Social Adjustment
Therapeutics
Mastectomy
Decision Making
Neoplasms
Patient Selection
Interviews

Cite this

Meiser, B. ; Quinn, V.F. ; Gleeson, M. ; Kirk, J. ; Tucker, K.M. ; Rahman, B. ; Saunders, Christobel ; Watts, K.J. ; Peate, M. ; Geelhoed, Elizabeth ; Barlow-Stewart, K. ; Field, M. ; Harris, M. ; Antill, Y.C. ; Mitchell, G. / When knowledge of a heritable gene mutation comes out of the blue: Treatment-focused genetic testing in women newly diagnosed with breast cancer. In: European Journal of Human Genetics. 2016 ; Vol. 24, No. 11. pp. 1517-1523.
@article{025f76b7bac5439eaa90a347722b3b6a,
title = "When knowledge of a heritable gene mutation comes out of the blue: Treatment-focused genetic testing in women newly diagnosed with breast cancer",
abstract = "{\circledC} 2016 Macmillan Publishers Limited, part of Springer Nature.Selection of women for treatment-focused genetic testing (TFGT) following a new diagnosis of breast cancer is changing. Increasingly a patient's age and tumour characteristics rather than only their family history are driving access to TFGT, but little is known about the impact of receiving carrier-positive results in individuals with no family history of cancer. This study assesses the role of knowledge of a family history of cancer on psychosocial adjustment to TFGT in both women with and without mutation carrier-positive results. In-depth semistructured interviews were conducted with 20 women who had undergone TFGT, and who had been purposively sampled to represent women both family history and carrier status, and subjected to a rigorous qualitative analysis. It was found that mutation carriers without a family history reported difficulties in making surgical decisions quickly, while in carriers with a family history, a decision regarding surgery, electing for bilateral mastectomy (BM), had often already been made before receipt of their result. Long-term adjustment to a mutation-positive result was hindered by a sense of isolation not only by those without a family history but also those with a family history who lacked an affected relative with whom they could identify. Women with a family history who had no mutation identified and who had not elected BM reported a lack of closure following TFGT. These findings indicate support deficits hindering adjustment to positive TFGT results for women with and without a family history, particularly in regard to immediate decision-making about risk-reducing surgery.",
author = "B. Meiser and V.F. Quinn and M. Gleeson and J. Kirk and K.M. Tucker and B. Rahman and Christobel Saunders and K.J. Watts and M. Peate and Elizabeth Geelhoed and K. Barlow-Stewart and M. Field and M. Harris and Y.C. Antill and G. Mitchell",
year = "2016",
doi = "10.1038/ejhg.2016.69",
language = "English",
volume = "24",
pages = "1517--1523",
journal = "European Journal of Human Genetics",
issn = "1018-4813",
publisher = "Nature Publishing Group - Macmillan Publishers",
number = "11",

}

Meiser, B, Quinn, VF, Gleeson, M, Kirk, J, Tucker, KM, Rahman, B, Saunders, C, Watts, KJ, Peate, M, Geelhoed, E, Barlow-Stewart, K, Field, M, Harris, M, Antill, YC & Mitchell, G 2016, 'When knowledge of a heritable gene mutation comes out of the blue: Treatment-focused genetic testing in women newly diagnosed with breast cancer' European Journal of Human Genetics, vol. 24, no. 11, pp. 1517-1523. https://doi.org/10.1038/ejhg.2016.69

When knowledge of a heritable gene mutation comes out of the blue: Treatment-focused genetic testing in women newly diagnosed with breast cancer. / Meiser, B.; Quinn, V.F.; Gleeson, M.; Kirk, J.; Tucker, K.M.; Rahman, B.; Saunders, Christobel; Watts, K.J.; Peate, M.; Geelhoed, Elizabeth; Barlow-Stewart, K.; Field, M.; Harris, M.; Antill, Y.C.; Mitchell, G.

In: European Journal of Human Genetics, Vol. 24, No. 11, 2016, p. 1517-1523.

Research output: Contribution to journalArticle

TY - JOUR

T1 - When knowledge of a heritable gene mutation comes out of the blue: Treatment-focused genetic testing in women newly diagnosed with breast cancer

AU - Meiser, B.

AU - Quinn, V.F.

AU - Gleeson, M.

AU - Kirk, J.

AU - Tucker, K.M.

AU - Rahman, B.

AU - Saunders, Christobel

AU - Watts, K.J.

AU - Peate, M.

AU - Geelhoed, Elizabeth

AU - Barlow-Stewart, K.

AU - Field, M.

AU - Harris, M.

AU - Antill, Y.C.

AU - Mitchell, G.

PY - 2016

Y1 - 2016

N2 - © 2016 Macmillan Publishers Limited, part of Springer Nature.Selection of women for treatment-focused genetic testing (TFGT) following a new diagnosis of breast cancer is changing. Increasingly a patient's age and tumour characteristics rather than only their family history are driving access to TFGT, but little is known about the impact of receiving carrier-positive results in individuals with no family history of cancer. This study assesses the role of knowledge of a family history of cancer on psychosocial adjustment to TFGT in both women with and without mutation carrier-positive results. In-depth semistructured interviews were conducted with 20 women who had undergone TFGT, and who had been purposively sampled to represent women both family history and carrier status, and subjected to a rigorous qualitative analysis. It was found that mutation carriers without a family history reported difficulties in making surgical decisions quickly, while in carriers with a family history, a decision regarding surgery, electing for bilateral mastectomy (BM), had often already been made before receipt of their result. Long-term adjustment to a mutation-positive result was hindered by a sense of isolation not only by those without a family history but also those with a family history who lacked an affected relative with whom they could identify. Women with a family history who had no mutation identified and who had not elected BM reported a lack of closure following TFGT. These findings indicate support deficits hindering adjustment to positive TFGT results for women with and without a family history, particularly in regard to immediate decision-making about risk-reducing surgery.

AB - © 2016 Macmillan Publishers Limited, part of Springer Nature.Selection of women for treatment-focused genetic testing (TFGT) following a new diagnosis of breast cancer is changing. Increasingly a patient's age and tumour characteristics rather than only their family history are driving access to TFGT, but little is known about the impact of receiving carrier-positive results in individuals with no family history of cancer. This study assesses the role of knowledge of a family history of cancer on psychosocial adjustment to TFGT in both women with and without mutation carrier-positive results. In-depth semistructured interviews were conducted with 20 women who had undergone TFGT, and who had been purposively sampled to represent women both family history and carrier status, and subjected to a rigorous qualitative analysis. It was found that mutation carriers without a family history reported difficulties in making surgical decisions quickly, while in carriers with a family history, a decision regarding surgery, electing for bilateral mastectomy (BM), had often already been made before receipt of their result. Long-term adjustment to a mutation-positive result was hindered by a sense of isolation not only by those without a family history but also those with a family history who lacked an affected relative with whom they could identify. Women with a family history who had no mutation identified and who had not elected BM reported a lack of closure following TFGT. These findings indicate support deficits hindering adjustment to positive TFGT results for women with and without a family history, particularly in regard to immediate decision-making about risk-reducing surgery.

U2 - 10.1038/ejhg.2016.69

DO - 10.1038/ejhg.2016.69

M3 - Article

VL - 24

SP - 1517

EP - 1523

JO - European Journal of Human Genetics

JF - European Journal of Human Genetics

SN - 1018-4813

IS - 11

ER -